![Rodney Lappe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rodney Lappe
Directeur/Membre du Conseil chez
DESIGN THERAPEUTICS, INC.
Fortune : 2 M $ au 31/07/2026
Profil
Rodney W.
Lappe is currently Director at Nucleus Biologics LLC and Independent Director at Design Therapeutics, Inc. Former roles include Director at Mirati Therapeutics, Inc., Senior Vice President at Tavistock Life Sciences Co., VP-Cardiovascular & Metabolic Diseases at Pharmacia Corp., Group SVP-Worldwide Research & Development at Pfizer Inc., and Chief Scientific Officer & Senior Vice President at CovX Research LLC.
Education includes undergraduate studies at Blackburn College and a doctorate from Indiana University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/06/2026 | 133 024 ( 0,21 % ) | 2 M $ | 31/07/2026 |
Postes actifs de Rodney Lappe
| Sociétés | Poste | Début |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2019 |
Nucleus Biologics LLC
 Nucleus Biologics LLC BiotechnologyHealth Technology Develops cellular immunotherapies | Directeur/Membre du Conseil | - |
Anciens postes connus de Rodney Lappe
| Sociétés | Poste | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Président | 15/02/2019 |
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Manufactures biotherapeutics and medical products | Directeur Technique/Scientifique/R&D | 01/12/2011 |
| PFIZER INC. | Directeur Technique/Scientifique/R&D | 01/12/2011 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01/12/2003 |
Tavistock Life Sciences Co.
 Tavistock Life Sciences Co. Investment ManagersFinance Tavistock Life Sciences invests in both public and private companies located in the United States. The firm focuses on life science companies with exceptional technology profiles. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Formation de Rodney Lappe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Blackburn College
 Blackburn College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tavistock Life Sciences Co.
Tavistock Life Sciences Co. Investment ManagersFinance Tavistock Life Sciences invests in both public and private companies located in the United States. The firm focuses on life science companies with exceptional technology profiles. It provides financing for early stage capital requirements. | Finance |
CovX Research LLC
CovX Research LLC BiotechnologyHealth Technology Manufactures biotherapeutics and medical products | Health Technology |
Nucleus Biologics LLC
Nucleus Biologics LLC BiotechnologyHealth Technology Develops cellular immunotherapies | Health Technology |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
